2026 Q1 Portfolio Activity
In 2026 Q1, Foresite Capital Management VI LLC maintained a portfolio of 19 distinct positions. The most significant new addition was Minerva Neurosciences, Inc., now representing 2.60% of the total fund value. They heavily accumulated shares in Corvus Pharmaceuticals, Inc., increasing the position by 32.6%. Conversely, Foresite Capital Management VI LLC completely exited their position in RAPT Therapeutics, Inc..
Position History
hover any row below to update
Loading…
Total Positions
19
Quarter
2026 Q1
Top Holding
CGON (32.7%)
Top 10 Concentration
90.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-19 of 19
Foresite Capital Management VI LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CGON
CG Oncology, In...
|
Healthcare | 32.67% | 27.88% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
2,221,474 | $150,349,360 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALMS
ALUMIS INC.
|
Healthcare | 20.33% | 12.53% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
4,247,670 | $93,576,170 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTA
Centessa Pharma...
|
Healthcare | 11.77% | 10.31% |
#3
1
Prev: #4
|
6.0 |
—
|
no change | no change |
P
S
|
1,364,019 | $54,178,835 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
Corvus Pharmace...
|
Healthcare | 5.82% | 3.21% |
#4
7
Prev: #11
|
5.3 |
—
|
450,000 | 32.6% |
P
S
|
1,831,233 | $26,790,939 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNLI
Denali Therapeu...
|
Healthcare | 5.05% | 4.99% |
#5
1
Prev: #6
|
5.0 |
—
|
209,971 | 21.0% |
P
S
|
1,209,971 | $23,231,443 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 3.86% | 4.36% |
#6
2
Prev: #8
|
2.0 |
—
|
-5,000 | -0.9% |
P
S
|
525,000 | $17,760,750 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VSTM
Verastem, Inc.
|
Healthcare | 3.62% | 7.32% |
#7
2
Prev: #5
|
1.9 |
—
|
11,511 | 0.4% |
P
S
|
3,146,631 | $16,677,144 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KYMR
Kymera Therapeu...
|
Healthcare | 2.65% | 3.44% |
#8
1
Prev: #9
|
2.1 |
—
|
no change | no change |
P
S
|
146,332 | $12,187,992 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NERV
Minerva Neurosc...
|
Healthcare | 2.60% | — |
#9
Prev: #—
|
4.5 |
—
|
1,986,600 | — |
NEW
|
1,986,600 | $11,969,265 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLDX
Celldex Therape...
|
Healthcare | 2.18% | — |
#10
Prev: #—
|
4.4 |
—
|
315,913 | — |
NEW
|
315,913 | $10,020,760 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ATAI
AtaiBeckley Inc...
|
Healthcare | 2.12% | 3.40% |
#11
1
Prev: #10
|
1.8 |
—
|
no change | no change |
P
S
|
2,750,000 | $9,735,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HNGE
Hinge Health, I...
|
Healthcare | 1.85% | 1.90% |
#12
Prev: #12
|
3.7 |
—
|
85,400 | 63.3% |
P
S
|
220,400 | $8,498,624 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRNX
Crinetics Pharm...
|
Healthcare | 1.67% | — |
#13
Prev: #—
|
4.2 |
—
|
212,010 | — |
NEW
|
212,010 | $7,700,203 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OKUR
OnKure Therapeu...
|
Healthcare | 1.30% | — |
#14
Prev: #—
|
4.0 |
—
|
1,445,783 | — |
NEW
|
1,445,783 | $5,985,542 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 0.98% | — |
#15
Prev: #—
|
3.9 |
—
|
320,000 | — |
NEW
|
320,000 | $4,496,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GHRS
GH Research PLC
|
Healthcare | 0.96% | — |
#16
Prev: #—
|
3.9 |
—
|
315,492 | — |
NEW
|
315,492 | $4,435,818 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZURA
Zura Bio Ltd
|
Healthcare | 0.58% | — |
#17
Prev: #—
|
3.7 |
—
|
450,000 | — |
NEW
|
450,000 | $2,677,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTRA
Natera, Inc.
|
Healthcare | 0.00% | 4.66% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-67,356 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPT
RAPT Therapeuti...
|
Healthcare | 0.00% | 16.00% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-1,562,500 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-19 of 19 holdings